CrossrefInfokarte
The efficacy of intraoperative onabotulinumtoxinA in preventing hypertrophic scarring: a randomised, double-blind, split-scar trial with biomarker analysis
Advances in Dermatology and Allergology · 2026 · 43 (5) · 535-542
DOI: 10.5114/ada.2026.165985 ↗Abstract
Kein Abstract verfügbar.
EUVIMED